Committee on Utilization Review and Education

Practice tips. Surveillance for type 2 diabetes and its complications. Committee on Utilization Review and Education

2000NationalCanadian family physician Medecin de famille canadien

Canada

Read the PDF Original at the sourceAsk Osler about this guideline

Read the guideline

Full guideline, as published72 KBOpen in a new tab Download

Source and rights

Published by Canadian family physician Medecin de famille canadien, 2000. The PDF is shown as published and remains the work of its authors and publisher; the original is at the source linked here. Rights holders can ask us to remove a file at info@prognia.nl.

pmc.ncbi.nlm.nih.gov/articles/PMC1987662/

Ask a question about this guideline.

Osler answers from this library and names the guideline behind every claim.

Discover Osler

Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.

At a glance

Organisation: Committee on Utilization Review and Education
Published: 2000
Applies to: 🇨🇦 Canada
Scope: National
Journal: Canadian family physician Medecin de famille canadien
PubMed: 10660789
PubMed Central: PMC1987662
Added to Prognia: 25 July 2026

Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of EndocrinologyWorld Health Organization · 2026Added 23 Jul 2026

Diabetes technology (Update 2026)Wiener klinische Wochenschrift · 2026Added 23 Jul 2026PDF

ISPAD Position Statement on Type 1 Diabetes in SchoolsInternational Society for Pediatric and Adolescent Diabetes · 2026Added 18 Jul 2026PDF

SICOB Italian Clinical Practice GRADE-based guidelines for the endobariatric treatment of overweight, obesity, and obesity-associated diseasesUpdates in surgery · 2026Added 18 Jul 2026PDF

Part 2: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Risk Stratifying Patients With MASLD.Dysfunction-Associated Steatotic Liver Disease Working Group · 2026Added 18 Jul 2026PDF

Part 3: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Ultrasound Shear Wave Elastography and MR Elastography Program Implementation, Funding, and Quality AssuranceDysfunction-Associated Steatotic Liver Disease Working Group · 2026Added 18 Jul 2026PDF

Part 1: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Guidance Statements for Detecting and Grading Hepatic Steatosis Using Ultrasound, CT, or MRI.Dysfunction-Associated Steatotic Liver Disease Working Group · 2026Added 18 Jul 2026PDF

Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025Endocrine Society · 2026Added 18 Jul 2026PDF

European Association for the Study of Obesity Position Statement on the Diagnosis and Management of Obesity in Older AdultsObesity facts · 2026Added 18 Jul 2026PDF

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026American Diabetes Association · 2026Added 18 Jul 2026PDF